TCT-834 Comparison of Two-Year Clinical Outcomes Between Ostial Stenting and Crossover Stenting for Ostial Left Anterior Descending Artery Lesions

Background Recently, stent implantation for ostial left anterior descending coronary artery (LAD) lesions has become a common clinical practice; however, the efficacy and safety of LAD ostial stenting (OS) and distal left main coronary artery (LMCA) to LAD crossover stenting (CS) is not well known. MACE defined as a composite of cardiac death, myocardial infarction (MI), stent thrombosis (ST) and clinical driven target lesion revascularization (TLR). [...]there were no significant differences in other outcomes (cardiac death 0% vs. 2.0%, p=0.30; MI 0% vs. 0%; ST 0% vs. 0%; TLR 6.0% vs. 0%, p=0.07).